People

Palamar-276-303
Joseph Palamar, PhD, MPH
NYU Langone Health - Associate Professor, Department of Population Health
Email: joseph.palamar@nyu.edu
Education
PhD, Public Health, New York University
MPH, Public Health, New York University
MA, Educational Psychology, New York University
BA, Forensic Psychology, John Jay College of Criminal Justice
Research Interests
Epidemiology of illicit drug use, club drugs, new psychoactive substances, stigma, risky sexual intercourse
BIO
Joseph Palamar’s research and publication record reflect his commitment to investigate the epidemiology of drug use. He has a diverse background in psychology, epidemiology, and in the study of drug use, and specializes in psychosocial correlates of drug use. He has focused heavily on the epidemiology of new psychoactive substance use, “club drug” use, and drug-related risky sexual behavior — especially within the electronic dance music (EDM) nightclub and festival scene. He also has extensive experience analyzing data from large national datasets such as Monitoring the Future and the National Survey on Drug Use and Health.
Projects
Principal Investigator, Investigating the Ketamine Landscape: Availability, Medical and Recreational Use, and Effects. Active
Principal Investigator, New Psychoactive Substance Exposure among NYC Nightclub and Festival Attendees. Active
Principal Investigator, Development of a Rapid Survey to Detect Use of New and Emerging Drugs. Completed
Principal Investigator, Drug Use Among Nightclub and Dance Festival Attendees in New York City. Completed
Principal Investigator, Pilot Study Examining the Sexual Effects of Cannabis Use. Completed
Principal Investigator, Pilot Study to Collect Saliva and Follow-up Survey Response Rates among EDM Party Attendees. Completed
Principal Investigator, Use of Psychoactive Drugs and Sexual Risk Behavior among Nightclub and Festival Attendees. Completed
Publications

Recent

Palamar JJ (2024).
Illicitly manufactured fentanyl use among individuals in the U.S., 2022
American Journal of Preventive Medicine, 67 (2), 285-290. doi: 10.1016/j.amepre.2024.03.014. PMCID: PMC11260524.

Fitzgerald ND, Cottler LB, Palamar JJ (2024).
Public health surveillance of new psychoactive substances: Recent developments
Current Opinion in Psychiatry, 37 (4), 270-276. doi: 10.1097/YCO.0000000000000938. PMCID: PMC11142873.

Palamar JJ, Fitzgerald ND, Carr TH, Cottler LB, Ciccarone D (2024).
National and regional trends in fentanyl seizures in the United States, 2017-2023
International Journal of Drug Policy [Epub 2024 May 13]. doi: 10.1016/j.drugpo.2024.104417.

Gatanaga O, Palamar JJ, Lim S (2024).
Prevalence of substance use among Asian sexual minority individuals in the United States, 2015-2020
Journal of Psychoactive Drugs, 56 (2), 257-263. doi: 10.1080/02791072.2023.2181242. PMCID: PMC10460460.

Palamar JJ, Fitzgerald ND, Carr TH, Rutherford C, Keyes KM, Cottler LB (2024).
National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022
Drug and Alcohol Dependence, 258, 111086. doi: 10.1016/j.drugalcdep.2024.111086. PMCID: PMC11088526.

Dr. Palamar's MyBibliography Profile
Selected Press